Advances in cytological mechanism of neural invasion in pancreatic ductal adenocarcinoma

doi:10.3969/j.issn.1674-8115.2022.06.020

Abstract

Abstract:

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic malignant tumor, and the incidence of neural invasion of PDAC is as high as 80%?98%, far higher than any other solid tumor. Its neural invasion is defined as the discovery of PDAC cells in the nerve adventitia, perinerve and neurointima surrounding the nerve/nerve sheath. Many studies have shown that the occurrence of neural invasion in PDAC is closely related to faster disease progression, higher local recurrence rate and worse prognosis. The neural invasion of PDAC is related to the behavior/interaction of various types of specific/non-specific immune cells and glial-related cells in the pancreatic tumor microenvironment. These behaviors run through the progression of PDAC. Studies show that Schwann cells, pancreatic stellate cells, tumor-associated macrophages and even T cells, are related to the occurrence of neural invasion of PDAC, which is based on the cell-cell interaction of the above cells and a series of intracellular signal pathways. This review summarizes and introduces the research progress in the field of cytological mechanism of PDAC neural invasion in recent years. Detailed studies of its mechanism may contribute to the discovery of new targets and treatment methods, provide a theoretical basis for controlling or even reversing the neural invasion process of PDAC in the future, and make it possible to improve the prognosis of patients with PDAC.

Key words: pancreatic ductal adenocarcinoma (PDAC), neural invasion, tumor immune microenvironment, cytological mechanism, tumor metastasis

CLC Number:

R735.9

ZHANG Xiuqi, SHEN Baiyong. Advances in cytological mechanism of neural invasion in pancreatic ductal adenocarcinoma[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(6): 833-838.

TrendMD

References 29

1	SIEGEL R L, MILLER K D, FUCHS H E, et al. Cancer statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1): 7-33.
2	GROSSBERG A J, CHU L C, DEIG C R, et al. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma[J]. CA Cancer J Clin, 2020, 70(5): 375-403.
3	LIEBIG C, AYALA G, WILKS J A, et al. Perineural invasion in cancer: a review of the literature[J]. Cancer, 2009, 115(15): 3379-3391.
4	STOPCZYNSKI R E, NORMOLLE D P, HARTMAN D J, et al. Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma[J]. Cancer Res, 2014, 74(6): 1718-1727.
5	DEMIR I E, CEYHAN G O, LIEBL F, et al. Neural invasion in pancreatic cancer: the past, present and future[J]. Cancers, 2010, 2(3): 1513-1527.
6	NAKAO A, HARADA A, NONAMI T, et al. Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer[J]. Pancreas, 1996, 12(4): 357-361.
7	SCHORN S, DEMIR I E, HALLER B, et al. The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis[J]. Surg Oncol, 2017, 26(1): 105-115.
8	LIANG D K, SHI S, XU J, et al. New insights into perineural invasion of pancreatic cancer: more than pain[J]. Biochim Biophys Acta BBA Rev Cancer, 2016, 1865(2): 111-122.
9	AMIT M, NA'ARA S, GIL Z. Mechanisms of cancer dissemination along nerves[J]. Nat Rev Cancer, 2016, 16(6): 399-408.
10	MU W, WANG Z, ZÖLLER M. Ping-pong-tumor and host in pancreatic cancer progression[J]. Front Oncol, 2019, 9: 1359.
11	NA'ARA S, AMIT M, GIL Z. L1CAM induces perineural invasion of pancreas cancer cells by upregulation of metalloproteinase expression[J]. Oncogene, 2019, 38(4): 596-608.
12	BAKST R L, XIONG H Z, CHEN C H, et al. Inflammatory monocytes promote perineural invasion via CCL2-mediated recruitment and cathepsin B expression[J]. Cancer Res, 2017, 77(22): 6400-6414.
13	DEBORDE S, WONG R J. How Schwann cells facilitate cancer progression in nerves[J]. Cell Mol Life Sci, 2017, 74(24): 4405-4420.
14	BRESSY C, LAC S, NIGRI J, et al. LIF drives neural remodeling in pancreatic cancer and offers a new candidate biomarker[J]. Cancer Res, 2018, 78(4): 909-921.
15	ZENG L J, GUO Y B, LIANG J Z, et al. Perineural invasion and TAMs in pancreatic ductal adenocarcinomas: review of the original pathology reports using immunohistochemical enhancement and relationships with clinicopathological features[J]. J Cancer, 2014, 5(9): 754-760.
16	ARIMA K, KOMOHARA Y, BU L K, et al. Downregulation of 15-hydroxyprostaglandin dehydrogenase by interleukin-1β from activated macrophages leads to poor prognosis in pancreatic cancer[J]. Cancer Sci, 2018, 109(2): 462-470.
17	CAVEL O, SHOMRON O, SHABTAY A, et al. Endoneurial macrophages induce perineural invasion of pancreatic cancer cells by secretion of GDNF and activation of RET tyrosine kinase receptor[J]. Cancer Res, 2012, 72(22): 5733-5743.
18	HUANG C M, LI Y Q, GUO Y B, et al. MMP1/PAR1/SP/NK1R paracrine loop modulates early perineural invasion of pancreatic cancer cells[J]. Theranostics, 2018, 8(11): 3074-3086.
19	VONLAUFEN A, JOSHI S, QU C F, et al. Pancreatic stellate cells: partners in crime with pancreatic cancer cells[J]. Cancer Res, 2008, 68(7): 2085-2093.
20	LI X Q, LIU H, XU Q H, et al. P-0095 sonic hedgehog paracrine signaling activates pancreatic stellate cells to promote the perineural invasion of pancreatic cancer in vivo[J]. Ann Oncol, 2012, 23: iv58-iv59.
21	FUJITA H, OHUCHIDA K, MIZUMOTO K, et al. Tumor-stromal interactions with direct cell contacts enhance proliferation of human pancreatic carcinoma cells[J]. Cancer Sci, 2009, 100(12): 2309-2317.
22	DE SIMONE R, AMBROSINI E, CARNEVALE D, et al. NGF promotes microglial migration through the activation of its high affinity receptor: modulation by TGF-β[J]. J Neuroimmunol, 2007, 190(1/2): 53-60.
23	YANG M W, TAO L Y, JIANG Y S, et al. Perineural invasion reprograms the immune microenvironment through cholinergic signaling in pancreatic ductal adenocarcinoma[J]. Cancer Res, 2020, 80(10): 1991-2003.
24	DANG C X, ZHANG Y, MA Q Y, et al. Expression of nerve growth factor receptors is correlated with progression and prognosis of human pancreatic cancer[J]. J Gastroenterol Hepatol, 2006, 21(5): 850-858.
25	DEMIR I E, CEYHAN G O, RAUCH U, et al. The microenvironment in chronic pancreatitis and pancreatic cancer induces neuronal plasticity[J]. Neurogastroenterol Motil, 2010, 22(4): 480-490, e112-e113.
26	KONDO N, MURAKAMI Y, UEMURA K, et al. Su1826 increased number of perineural invasion is independently associated with poor survival of patients with resectable pancreatic cancer[J]. Gastroenterology, 2014, 146(5): S-1046.
27	FUJII-NISHIMURA Y, YAMAZAKI K, MASUGI Y, et al. Mesenchymal-epithelial transition of pancreatic cancer cells at perineural invasion sites is induced by Schwann cells[J]. Pathol Int, 2018, 68(4): 214-223.
28	TANAKA M, MIHALJEVIC A L, PROBST P, et al. Meta-analysis of recurrence pattern after resection for pancreatic cancer[J]. Br J Surg, 2019, 106(12): 1590-1601.
29	ALBANESE C, ALZANI R, AMBOLDI N, et al. Dual targeting of CDK and tropomyosin receptor kinase families by the oral inhibitor PHA-848125, an agent with broad-spectrum antitumor efficacy[J]. Mol Cancer Ther, 2010, 9(8): 2243-2254.

[1]	XU Jingxuan, DU Shaoqian, CAO Yuan, WANG Hongxia, HUANG Weiyi. MMP14 expression in pancreatic cancer and its correlation with characteristics of tumor immune microenvironment [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(3): 312-322.
[2]	Meng-ke LIU, Meng-meng JI, Lin CHENG, Jin-yan HUANG, Xiao-jian SUN, Wei-li ZHAO, Li WANG. Research progress in anti-tumor effect and mechanism of baicalin [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(2): 246-250.
[3]	LIU Bo, QIU Chun, LI Peng, et al. Effects of targeted knockout of JARID2 gene on growth and migration of uveal melanoma cells [J]. , 2015, 35(5): 642-.